Literature DB >> 23869946

Mycobacterium tuberculosis DNA gyrase possesses two functional GyrA-boxes.

Aurélie Bouige1, Amélie Darmon, Jérémie Piton, Mélanie Roue, Stéphanie Petrella, Estelle Capton, Patrick Forterre, Alexandra Aubry, Claudine Mayer.   

Abstract

In contrast with most bacteria which possess two type II topoisomerases (topoisomerase IV and DNA gyrase), Mycobacterium tuberculosis possesses only one, DNA gyrase, which is functionally a hybrid enzyme. Functional differences between the two type IIA topoisomerases are thought to be specified by a CTD (C-terminal DNA-binding domain), which controls DNA recognition. To explore the molecular mechanism responsible for the hybrid functions of the M. tuberculosis DNA gyrase, we conducted a series of sequence analyses and structural and biochemical experiments with the isolated GyrA CTD and the holoenzyme. Although the CTD displayed a global structure similar to that of bona fide GyrA and ParC paralogues, it harbours a second key motif similar in all respects to that of the conserved GyrA-box sequence motif. Biochemical assays showed that the GyrA-box is responsible for DNA supercoiling, whereas the second GyrA-box-l (GyrA-box-like motif) is responsible for the enhanced decatenation activity, suggesting that the mechanistic originality of M. tuberculosis DNA gyrase depends largely on the particular DNA path around the CTD allowed for by the presence of GyrA-box-l. The results of the present study also provide, through phylogenetic exploration of the entire Corynebacterineae suborder, a new and broader insight into the functional diversity of bacterial type IIA topoisomerases.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23869946     DOI: 10.1042/BJ20130430

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  9 in total

Review 1.  What makes a type IIA topoisomerase a gyrase or a Topo IV?

Authors:  Jana Hirsch; Dagmar Klostermeier
Journal:  Nucleic Acids Res       Date:  2021-06-21       Impact factor: 16.971

2.  Recognition of DNA Supercoil Geometry by Mycobacterium tuberculosis Gyrase.

Authors:  Rachel E Ashley; Tim R Blower; James M Berger; Neil Osheroff
Journal:  Biochemistry       Date:  2017-09-25       Impact factor: 3.162

3.  Interactions between Quinolones and Bacillus anthracis Gyrase and the Basis of Drug Resistance.

Authors:  Rachel E Ashley; R Hunter Lindsey; Sylvia A McPherson; Charles L Turnbough; Robert J Kerns; Neil Osheroff
Journal:  Biochemistry       Date:  2017-08-01       Impact factor: 3.162

4.  Structural basis for allosteric regulation of Human Topoisomerase IIα.

Authors:  Arnaud Vanden Broeck; Christophe Lotz; Robert Drillien; Léa Haas; Claire Bedez; Valérie Lamour
Journal:  Nat Commun       Date:  2021-05-20       Impact factor: 14.919

5.  Functional Analyses of the Toxoplasma gondii DNA Gyrase Holoenzyme: A Janus Topoisomerase with Supercoiling and Decatenation Abilities.

Authors:  Ting-Yu Lin; Soshichiro Nagano; Jonathan Gardiner Heddle
Journal:  Sci Rep       Date:  2015-09-28       Impact factor: 4.379

6.  Eagle Effect in Nonreplicating Persister Mycobacteria.

Authors:  Mu-Lu Wu; Jasmie Tan; Thomas Dick
Journal:  Antimicrob Agents Chemother       Date:  2015-09-08       Impact factor: 5.191

7.  Investigating the Roles of the C-Terminal Domain of Plasmodium falciparum GyrA.

Authors:  Soshichiro Nagano; Eiko Seki; Ting-Yu Lin; Mikako Shirouzu; Shigeyuki Yokoyama; Jonathan G Heddle
Journal:  PLoS One       Date:  2015-11-13       Impact factor: 3.240

8.  Modulated control of DNA supercoiling balance by the DNA-wrapping domain of bacterial gyrase.

Authors:  Matthew J Hobson; Zev Bryant; James M Berger
Journal:  Nucleic Acids Res       Date:  2020-02-28       Impact factor: 16.971

9.  Analysing non-synonymous mutations in XDR and MDR tuberculosis drugs.

Authors:  Pallavi Surana; Ashwin Kumar Jainarayanan; Nithishwer Mouroug Anand; Mukta Sharma
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2019-09-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.